Posted by Michael Wonder on 07 Feb 2019
Congress invites 7 drug makers to testify at potentially hostile hearing on drug prices. Here's what they're saying
6 February 2019 - Bristol-Myers Squibb, Pfizer, Merck and Sanofi have agreed to send their CEOs to Washington.
Drug makers have been reluctant to agree to testify before Congress at what is shaping up to be a series of hostile hearings examining the industry's drug pricing practices.
None of the companies "invited" to speak at last week's Senate Finance Committee hearing titled "Drug Pricing in America: A Prescription for Change, Part I" showed. But pharmaceutical companies are starting to come around this week, after some not-so-veiled threats by senators to "compel" their executives to testify, likely with subpoenas.
